Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)
GLP-1 Plus is a compounded medication with Semaglutide and B Vitamins, used primarily to treat type 2 diabetes and obesity
Their finding marked a decisive breakthrough because it challenged a long-standing belief that nerves controlled the secretion of digestive enzymes that had grown out of the work of Ivan Pavlov, the Russian physiologist who demonstrated that dogs can be conditioned to salivate by the sound of a bell (Rehfeld 2012)
We know that injections arent suitable for everyone, which is why we also offer oral medication for effective weight loss
Practical Takeaways for Patients GLP-1 medications arent just for weight loss they improve metabolic and cardiovascular health
Tirzepatide is a dual GLP/GIP agonist, while semaglutide is only a GLP-1 agonist